(2024). Oral analogues of GLP-1: Perspectives on glycemic control and cardiorenal risk in patients with type 2 diabetes mellitus.
Chicago Style (17th ed.) CitationOral Analogues of GLP-1: Perspectives on Glycemic Control and Cardiorenal Risk in Patients with Type 2 Diabetes Mellitus. 2024.
MLA (8th ed.) CitationOral Analogues of GLP-1: Perspectives on Glycemic Control and Cardiorenal Risk in Patients with Type 2 Diabetes Mellitus. 2024.
Warning: These citations may not always be 100% accurate.
